DWA
PJP icon

Dorsey Wright & Associates’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Dorsey Wright & Associates’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-1,200
Closed -$51K – 124
2013
Q2 		$51K Buy
+1,200
New +$49.9K 0.01% 119

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
NCM
Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
PFG
Pacific Financial Group Bellevue, Washington $209M AUM 22.2% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Dorsey Wright & Associates's PJP Position: Q3 2013 in Review

Dorsey Wright & Associates sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2013, closing a stake of 1,200 shares — an estimated $51K sold.

Dorsey Wright & Associates first reported a position in PJP in Q2 2013 and held it in 1 quarter. The position peaked at $51K in Q2 2013. 69 funds tracked by Wall St. Rank hold PJP as of Q3 2013.

  • Dorsey Wright & Associates reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2013 after selling out during the quarter.
  • Dorsey Wright & Associates sold 1,200 Invesco Pharmaceuticals ETF shares in Q3 2013, an estimated $51K.
  • Dorsey Wright & Associates first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and held it in 1 quarter.
  • Dorsey Wright & Associates's Invesco Pharmaceuticals ETF position peaked at $51K in Q2 2013.
  • 69 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2013.

Based on Dorsey Wright & Associates's 13F filing for Q3 2013, filed 23 Oct 2013.